Literature DB >> 22386175

Opioid-abusing health care professionals: options for treatment and returning to work after treatment.

Marvin D Seppala, Michael R Oreskovich.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22386175      PMCID： PMC3498284          DOI： 10.1016/j.mayocp.2012.02.002

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  10 in total

1.  Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial.

Authors:  Roger D Weiss; Jennifer Sharpe Potter; David A Fiellin; Marilyn Byrne; Hilary S Connery; William Dickinson; John Gardin; Margaret L Griffin; Marc N Gourevitch; Deborah L Haller; Albert L Hasson; Zhen Huang; Petra Jacobs; Andrzej S Kosinski; Robert Lindblad; Elinore F McCance-Katz; Scott E Provost; Jeffrey Selzer; Eugene C Somoza; Susan C Sonne; Walter Ling
Journal:  Arch Gen Psychiatry       Date:  2011-11-07

2.  Evidence of addiction by anesthesiologists as documented by hair analysis.

Authors:  P Kintz; M Villain; V Dumestre; V Cirimele
Journal:  Forensic Sci Int       Date:  2005-10-04       Impact factor: 2.395

3.  How are addicted physicians treated? A national survey of Physician Health Programs.

Authors:  Robert L DuPont; A Thomas McLellan; Gary Carr; Michael Gendel; Gregory E Skipper
Journal:  J Subst Abuse Treat       Date:  2009-07

Review 4.  Chemical dependency and the physician.

Authors:  Keith H Berge; Marvin D Seppala; Agnes M Schipper
Journal:  Mayo Clin Proc       Date:  2009-07       Impact factor: 7.616

5.  Buprenorphine maintenance therapy in opioid-addicted health care professionals returning to clinical practice: a hidden controversy.

Authors:  Heather Hamza; Ethan O Bryson
Journal:  Mayo Clin Proc       Date:  2012-03       Impact factor: 7.616

6.  Narcotic addiction, physical dependence and relapse.

Authors:  V P Dole
Journal:  N Engl J Med       Date:  1972-05-04       Impact factor: 91.245

7.  Safety and side-effects of buprenorphine in the clinical management of heroin addiction.

Authors:  W R Lange; P J Fudala; E M Dax; R E Johnson
Journal:  Drug Alcohol Depend       Date:  1990-08       Impact factor: 4.492

8.  Illicit use of buprenorphine/naloxone among injecting and noninjecting opioid users.

Authors:  Alexander R Bazazi; Michael Yokell; Jeannia J Fu; Josiah D Rich; Nickolas D Zaller
Journal:  J Addict Med       Date:  2011-09       Impact factor: 3.702

9.  Outcomes of buprenorphine maintenance in office-based practice.

Authors:  Stephen Magura; Stephen J Lee; Edwin A Salsitz; Andrew Kolodny; Susan D Whitley; Tanaquil Taubes; Randy Seewald; Herman Joseph; Deborah J Kayman; Chunki Fong; Lisa A Marsch; Andrew Rosenblum
Journal:  J Addict Dis       Date:  2007

10.  Five year outcomes in a cohort study of physicians treated for substance use disorders in the United States.

Authors:  A Thomas McLellan; Gregory S Skipper; Michael Campbell; Robert L DuPont
Journal:  BMJ       Date:  2008-11-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.